1. ALLA AKTIER
  2. NYHETER
  3. ORTIVUS

Ortivus

Nyheter Ortivus Nyheter alla bolag

The contract for the delivery of MobiMed to Region Jämtland Härjedalen has now been signed

MAR

On September 6, 2023, Ortivus was awarded a contract for the delivery of MobiMed enRoute to Region Jämtland Härjedalen's ambulance operations. The contract has now been signed by both parties. The order value is estimated to 2.5 MSEK, and the contract duration is 8 years.

We are pleased to announce that a contract has been signed between Ortivus and Region Jämtland Härjedalen for the delivery of MobiMed enRoute to all of the region's ambulance vehicles. MobiMed enRoute is Ortivus' newly launched solution for navigation, case management, and mass casualty management.
 
Region Jämtland Härjedalen has been a long-standing customer of the company and has previously utilized MobiMed Monitor, MobiMed ePR, and MobiMed FleetCtrl. With the addition of MobiMed enRoute, the region will now receive an integrated and competitive total solution to enhance its prehospital care.
 
The contract primarily covers software licenses, but it also includes hardware, integrations with existing systems, and user training. Implementation is expected to commence in the fall of 2023.
 
"Region Jämtland Härjedalen is one of the first to implement our newly launched solution, MobiMed enRoute, in their prehospital care. We are very pleased with the region's continued trust and look forward to delivering state-of-the-art equipment for increased patient safety and efficiency", says Elias Obaid, Global Sales Manager at Ortivus.

Contacts

For further information, please contact

Reidar Gårdebäck, CEO

Telefon +46 8 446 45 00

About Ortivus

Ortivus develops and commercialises MobiMed, e-health and medical technology solutions for a safer and more efficient healthcare. The company was founded in 1985 and is today a leading provider of mobile digital solutions for prehospital care, worldwide. Ortivus' innovations are based on in-depth expertise in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm. The company has, since 1998, a wholly owned subsidiary based in the United Kingdom and since 2022, a wholly owned subsidiary based in Denmark.

MobiMed is a modular platform that connects and enable real-time information sharing throughout the prehospital care chain. It is currently used by over 12,000 paramedics in over 2,700 emergency vehicles. The platform, MobiMed, consists of several product modules that are completely integrated but can also be used stand-alone. MobiMed comprises four main solutions: MobiMed Monitor, that measures, monitors and shares patients' vital parameters and ECG in real-time, MobiMed ePR, - an electronic patient record for decision support, collection of patient data and clinical documentation, MobiMed enRoute, - a tool for navigation and case management, and MobiMed Life - a range of stand-alone defibrillators.

MobiMed saves vital seconds and enable healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.

Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.
 
Read more about Ortivus at www.ortivus.com

This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-09-27 15:00 CEST.

Attachments

The contract for the delivery of MobiMed to Region Jämtland Härjedalen has now been signed

Datum 2023-09-27, kl 15:00
Källa MFN
Bifogade filer
The contract for the delivery of MobiMed to Region Jämtland Härjedalen has now been signed
Affiliate
SAVR är investeringsplattformen som utmanar branschen och gör det både enklare och roligare att investera. Betala aldrig för mycket! Alla aktier och ETF:er från 1 kr, och få upp till 50 % rabatt på alla fonder. Automatiskt courtage och samma enkla prismodell på alla marknader.
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet